Beneficial effect of atypical antipsychotics on prefrontal brain function in acute psychotic disorders

European Archives of Psychiatry and Clinical Neuroscience

Volumn 255, Issue 5, 2005, Pages 299-307

  Ehlis, Ann Christine ^a   Zielasek, Jürgen ^a   Herrmann, Martin J ^a   Ringel, Thomas ^a   Jacob, Christian ^a   Fallgatter, Andreas J ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Anterior cingulate cortex (ACC); Atypical antipsychotics; Cycloid psychosis; Nogo anteriorization (NGA); Schizophrenia

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CHLORPROMAZINE; CLOZAPINE; FLUPENTIXOL; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; PERAZINE; QUETIAPINE; RISPERIDONE;

ADULT; ARTICLE; BRAIN FUNCTION; BRIEF PSYCHOTIC DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; DRUG EFFECT; EVENT RELATED POTENTIAL; FEMALE; HUMAN; MALE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOAFFECTIVE PSYCHOSIS; TASK PERFORMANCE; TREATMENT OUTCOME;

ADULT; ANALYSIS OF VARIANCE; ANTIPSYCHOTIC AGENTS; BRAIN MAPPING; CHOICE BEHAVIOR; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PREFRONTAL CORTEX; PSYCHOTIC DISORDERS; STATISTICS, NONPARAMETRIC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 27744447091     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00406-005-0562-1     Document Type: Article

References (61)

1. Abbruzzese M, Ferri S, Scarone S (1997) The selective breakdown of frontal functions in patients with obsessive-compulsive disorder and in patients with schizophrenia: A double dissociation experimental finding. Neuropsychologia 35:907-912
2. Andreasen NC, Rezai K, Alliger R, Swayze VW 2nd, Flaum M, Kirchner P, Cohen G, O'Leary DS (1992) Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London. Arch Gen Psychiatry 49:943-958
3. Bartlett EJ, Brodie JD, Simkowitz P, Dewey SL, Rusinek H, Wolf AP, Fowler JS, Volkow ND, Smith G, Wolkin A (1994) Effects of haloperidol challenge on regional cerebral glucose utilization in normal human subjects. Am J Psychiatry 151:681-686
4. Berman I, Viegner B, Merson A, Allan E, Pappas D, Green AI (1997) Differential relationships between positive and negative symptoms and neuropsychological deficits in schizophrenia. Schizophr Res 25:1-10
5. Bilder RM, Goldman RS, Volavka J, Czobor P, Hoptman M, Sheitman B, Lindenmayer JP, Citrome L, McEvoy J, Kunz M, Chakos M, Cooper TB, Horowitz TL, Lieberman JA (2002) Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. Am J Psychiatry 159:1018-1028
6. Braus DF, Ende G, Weber-Fahr W, Demirakca T, Henn FA (2001) Favorable effect on neuronal viability in the anterior cingulate gyrus due to long-term treatment with atypical antipsychotics: an MRSI study. Pharmacopsychiatry 34:251-253
7. Braus DF, Ende G, Weber-Fahr W, Demirakca T, Tost H, Henn FA (2002) Functioning and neuronal viability of the anterior cingulate neurons following antipsychotic treatment: MR-spectroscopic imaging in chronic schizophrenia. Eur Neuropsychopharmacol 12:145-152
8. Canadian Cognition and Outcome Study Group (1998) Neuropsychological changes in early phase schizophrenia over twelve months of treatment with olanzapine, risperidone, or haloperidol. Schizophr Res 29:152-153
9. Carter CS, Mintun M, Nichols T, Cohen JD (1997) Anterior cingulate gyrus dysfunction and selective attention deficits in schizophrenia: [15O]H2O PET study during single-trial Stroop task performance. Am J Psychiatry 154:1670-1675
10. Cuesta MJ, Peralta V, Zarzuela A (2001) Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: a longitudinal study. Schizophr Res 48:17-28
11. Desco M, Gispert JD, Reig S, Sanz J, Pascau J, Sarramea F, Benito C, Santos A, Palomo T, Molina V (2003) Cerebral metabolic patterns in chronic and recent-onset schizophrenia. Psychiatry Res 122:125-135
12. Ehlis AC, Zielasek J, Herrmann MJ, Ringel T, Jacob C, Wagener A, Fallgatter AJ (2004) Evidence for unaltered brain electrical topography during prefrontal response control in cycloid psychoses. Int J Psychophysiol (in press)
13. Ende G, Braus DF, Walter S, Weber-Fahr W, Soher B, Maudsley AA, Henn FA (2000) Effects of age, medication, and illness duration on the N-acetyl aspartate signal of the anterior cingulate region in schizophrenia. Schizophr Res 41:389-395
14. Fallgatter AJ, Bartsch AJ, Herrmann MJ (2002) Electrophysiological measurements of anterior cingulate function. J Neural Transm 109:977-988
15. Fallgatter AJ, Bartsch AJ, Zielasek J, Herrmann MJ (2003) Brain-electrical dysfunction of the anterior cingulate in schizophrenic patients. Psychiatry Research: Neuroimaging 124:37-48
16. Fallgatter AJ, Brandeis D, Strik WK (1997) A robust assessment of the NoGo-Anteriorisation of P300 microstates in a cued Continuous Performance Test. Brain Topogr 9:295-302
17. Fallgatter AJ, Eisenack SS, Neuhauser B, Aranda D, Scheuerpflug P, Herrmann MJ (2000) Stability of late event-related potentials: topographical descriptors of motor control compared with the P300 amplitude. Brain Topogr 12:255-261
18. Fallgatter AJ, Müller TJ (2001) Electrophysiological signs of reduced prefrontal response control in schizophrenic patients. Psychiatry Res: Neuroimaging 107:19-28
19. Fallgatter AJ, Strik WK (1999) The NoGo-anteriorisation as a neurophysiological standard-index for cognitive response control. Int J Psychophysiol 32:115-120
20. Gallhofer B, Bauer U, Lis S, Krieger S, Gruppe H (1996) Cognitive dysfunction in schizophrenia: comparison of treatment with atypical antipsychotic agents and conventional neuroleptic drugs. Eur Neuropsychopharmacol 6(Suppl 2):S13-S20
21. Gorynia I, Campman V, Uebelhack R (2003) Intermanual coordination in relation to different clinical subgroups in right-handed patients with schizophrenic and other psychotic disorders. Eur Arch Psychiatry Clin Neurosci 253:53-59
22. Green MF, Marshall BD Jr, Wirshing WC, Ames D, Marder SR, McGurk S, Kern RS, Mintz J (1997) Does Risperidone improve verbal working memory in treatment-resistant schizophrenia? Am J Psychiatry 154:799-804
23. Hazlett EA, Buchsbaum MS, Jeu LA, Nenadic I, Fleischman MB, Shihabuddin L, Haznedar MM, Harvey PD (2000) Hypofrontality in unmedicated schizophrenia patients studied with PET during performance of a serial verbal learning task. Schizophr Res 43:33-46
24. Higashima M, Kawasaki Y, Urata K, Sakai N, Nagasawa T, Koshino Y, Sumiya H, Tonami N, Tsuji S, Matsuda H (2000) Regional cerebral blood flow in male schizophrenic patients performing an auditory discrimination task. Schizophr Res 42:29-39
25. Honey GD, Bullmore ET, Soni W, Varatheesan M, Williams SC, Sharma T (1999) Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia. Proc Natl Acad Sci USA 96:13432-13437
26. Ichikawa J, Dai J, O'Laughlin IA, Fowler WL, Meltzer HY (2002) Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum. Neuropsychopharmacology 26:325-339
27. Ichikawa J, Meltzer HY (1999) Relationship between dopaminergic and serotonergic neuronal activity in the frontal cortex and the action of typical and atypical antipsychotic drugs. Eur Arch Psychiatry Clin Neurosci 249(Suppl 4):90-98
28. Ingvar DH, Franzen G (1974) Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia. Acta Psychiatr Scand 50:425-462
29. Jabs BE, Pfuhlmann B, Bartsch AJ, Cetkovich-Bakmas MG, Stöber G (2002) Cycloid psychoses - from clinical concepts to biological foundations. J Neural Transm 109:907-919
30. Jaeger M, Hintermayr M, Bottlender R, Strauss A, Möller, H-J (2003) Course and outcome of first-admitted patients with acute and transient psychotic disorders (ICD-10:F23). Eur Arch Psychiatry Clin Neurosci 253:209-215
31. Jasper H (1958) Report of committee on methods of clinical exam in EEG. Electroencephalogr Clin Neurophysiol 10:370-375
32. Lahti AC, Holcomb HH, Weiler MA, Medoff DR, Frey KN, Hardin M, Tamminga CA (2004) Clozapine but not Haloperidol re-establishes normal task-activated rCBF patterns in schizophrenia within the anterior cingulate cortex. Neuropsychoparmacology 29:171-178
33. rd ed, Munich, p 237
34. Lee MA, Thompson PA, Meltzer HY (1994) Effects of clozapine on cognitive function in schizophrenia. J Clin Psychiatry 55 (Suppl B):82-87
35. nd ed, Amsterdam, pp 309-354
36. Lehmann D, Faber PL, Achermann P, Jeanmonod D, Gianotti LR, Pizzagalli D (2001) Brain sources of EEG gamma frequency during volitionally medication-induced, altered states of consciousness, and experience of the self. Psychiatry Res 108:111-121
37. Lehmann D, Skrandies W (1980) Reference-free identification of components of checkerboard-evoked multichannel potential fields. Electroencephalogr Clin Neurophysiol 48:609-621
38. nd ed, Vienna, New York, pp 61-75
39. Li XM, Perry KW, Wong DT, Bymaster FP (1998) Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum. Psychopharmacology (Berl) 136:153-161
40. Lidow MS, Williams GV, Goldman-Rakic PS (1998) The cerebral cortex: a case for a common site of action of antipsychotics. Trends Pharmacol Sci 19:136-140
41. Madsen AL, Keiding N, Karle A, Esbjerg S, Hemmingsen R (1998) Neuroleptics in progressive structural brain abnormalities in psychiatric illness. Lancet 352:784-785
42. Miller DD, Andreasen NC, O'Leary DS, Watkins GL, Boles Ponto LL, Hichwa RD (2001) Comparison of the Effects of Risperidone and Haloperidol on Regional Cerebral Blood Flow in Schizophrenia. Biol Psychiatry 49:704-715
43. Mulert C, Gallinat J, Pascual-Marqui R, Dorn H, Frick K, Schlattmann P, Mientus S, Herrmann WM, Winterer G (2001) Reduced event-related current density in the anterior cingulate cortex in schizophrenia. Neuroimage 13:589-600
44. Mulert C, Jäger L, Schmitt R, Bussfeld P, Pogarell O, Möller H-J, Juckel G, Hegerl U (2004) Integration of fMRI and simultaneous EEG: towards a comprehensive understanding of localization and time-course of brain activity in target detection. NeuroImage 22:83-94
45. Oldfield RC (1971) The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 9:97-113
46. Pascual-Marqui R (1999) Review of methods for solving the EEG inverse problem. Int J Bioelectromagnetism 1:75-86
47. Pascual-Marqui RD, Lehmann D, Koenig T, Kochi K, Merlo MC, Hell D, Koukkou M (1999) Low resolution brain electromagnetic tomography (LORETA) functional imaging in acute, neuroleptic-naive, first-episode, productive schizophrenia. Psychiatry Res 90:169-179
48. Pascual-Marqui RD, Michel CM, Lehmann D (1994) Low resolution electromagnetic tomography, a new method for localizing electrical activity in the brain. Int J Psychophysiol 18:49-65
49. Pehek EA, Yamamoto BK (1994) Differential effects of locally administered clozapine and haloperidol on dopamine efflux in the rat prefrontal cortex and caudate-putamen. J Neurochem 63: 2118-2124
50. Purdon SE, Malla A, Labelle A, Lit W (2001) Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol. J Psychiatry Neurosci 26:137-149
51. Riley EM, McGovern D, Mockler D, Doku VCK, OCeallaigh S, Fannon DG, Tennakoon L, Santamaria M, Soni W, Morris RG, Sharma T (2000) Neuropsychological functioning in first-episode psychosis - evidence of specific deficits. Schizophr Res 43:47-55
52. Rosvold HE, Mirsky A, Sarason I, Bransome ED Jr, Beck LH (1956) A continuous performance test of brain damage. J Consult Psychol 20:343-350
53. Stip E, Lussier I (1996) Effect of risperidone on cognition in patients with schizophrenia. Can J Psychiatry 41 (Suppl 8):35-40
54. Strik WK, Fallgatter AJ, Stoeber G, Franzek E, Beckmann H (1996) Specific P300 features in patients with cycloid psychosis. Acta Psychiatr Scand 94:471-476
55. Strik WK, Fallgatter AJ, Brandeis D, Pascual-Marqui R (1998) Three dimensional tomography of event-related potentials during response inhibition: evidence for phasic frontal lobe activation. Electroencephalogr Clin Neurophysiol 108:406-413
56. Vaiva G, Cottencin O, Llorca PM, Devos P, Dupont S, Mazas O, Rascle C, Thomas P, Steinling M, Goudemand M (2002) Regional cerebral blood flow in deficit/nondeficit types of schizophrenia according to SDS criteria. Prog Neuropsychopharmacol Biol Psychiatry 26:481-485
57. Velligan DI, Newcomer J, Pultz J, Csernansky J, Hoff AL, Mahurin R, Miller AL (2002) Does cognitive function improve with quetiapine in comparison to haloperidol? Schizophr Res 53:239-248
58. Vitacco D, Brandeis D, Pascual-Marqui R, Martin E (2002) Correspondence of event-related potential tomography and functional magnetic resonance imaging during language processing. Human Brain Mapping 17:4-12
59. Volz HP, Gaser C, Häger F, Rzanny R, Pönisch J, Mentzel HJ, Kaiser WA, Sauer H (1999) Decreased frontal activation in schizophrenics during stimulation with the Continuous Performance Test - a functional magnetic resonance imaging study. Eur Psychiatry 14:17-24
60. Winterer G, Mulert C, Mientus S, Gallinat J, Schlattmann P, Dorn H, Herrmann WM (2001) P300 and LORETA: comparison of normal subjects and schizophrenic patients. Brain Topogr 13: 299-313
61. Yücel M, Pantelis C, Stuart GW, Wood SJ, Maruff P, Velakoulis D, Pipingas A, Crowe SF, Tochon-Danguy HJ, Egan GF (2002) Anterior Cingulate Activation During Stroop Task Performance: A PET to MRI Coregistration Study of Individual Patients With Schizophrenia. Am J Psychiatry 159:251-254